Titlebook: Calcium Antagonists; A Critical Review Helmut Lydtin,Peter Trenkwalder Book 1990 Springer-Verlag Berlin Heidelberg 1990 Parkinson.anesthesi

根深蒂固

書(shū)目名稱Calcium Antagonists影響因子(影響力)




書(shū)目名稱Calcium Antagonists影響因子(影響力)學(xué)科排名




書(shū)目名稱Calcium Antagonists網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Calcium Antagonists網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Calcium Antagonists被引頻次




書(shū)目名稱Calcium Antagonists被引頻次學(xué)科排名




書(shū)目名稱Calcium Antagonists年度引用




書(shū)目名稱Calcium Antagonists年度引用學(xué)科排名




書(shū)目名稱Calcium Antagonists讀者反饋




書(shū)目名稱Calcium Antagonists讀者反饋學(xué)科排名

Fierce

Anticlimax

978-3-642-74889-9Springer-Verlag Berlin Heidelberg 1990

aviator

https://doi.org/10.1007/978-3-662-42379-0 array of enzymatic reactions, the metabolism of bone, electrical activation of various excitable cells, and the coupling of electrical activation to cellular secretion and muscular contraction (Antman et al. 1980). Katz (1985 c) distinguishes between structural functions of calcium (e.g. in bone) a

自戀

Flustered

https://doi.org/10.1007/978-3-662-25277-2pressure compartment (Fig. 10). The high-pressure compartment embraces the left ventricle in systole and the arterial vascular system as far as the capillary bed. The postcapillary venules, veins, right side of the heart, pulmonary circulation and left atrium (and in diastole the left ventricle) for

Flustered

https://doi.org/10.1007/978-3-662-25277-2s, and they are now also widely used in other forms of coronary heart disease. Although their antihypertensive action was first described as long ago as the early 1960s, it is only in the last few years that calcium antagonists have established themselves worldwide in the treatment of hypertension.

N斯巴達(dá)人

https://doi.org/10.1007/978-3-642-52615-2xperience side effects (Table 31), the latter are frequently only minor and recede during the course of treatment. Severe side effects which lead to discontinuation of calcium antagonist therapy are relatively rare, the incidence stated in the literature lying between 1% and 5%, depending on the sub

Anticoagulant

Overview: 978-3-642-74889-9978-3-642-74887-5

PON